Retinoic acid receptors: from molecular mechanisms to cancer therapy

A Di Masi, L Leboffe, E De Marinis, F Pagano… - Molecular aspects of …, 2015 - Elsevier
Retinoic acid (RA), the major bioactive metabolite of retinol or vitamin A, induces a spectrum
of pleiotropic effects in cell growth and differentiation that are relevant for embryonic …

Free radicals in the physiological control of cell function

W Dröge - Physiological reviews, 2002 - journals.physiology.org
At high concentrations, free radicals and radical-derived, nonradical reactive species are
hazardous for living organisms and damage all major cellular constituents. At moderate …

Differentiation therapy revisited

H de Thé - Nature Reviews Cancer, 2018 - nature.com
The concept of differentiation therapy emerged from the fact that hormones or cytokines may
promote differentiation ex vivo, thereby irreversibly changing the phenotype of cancer cells …

Arsenic in medicine: past, present and future

NP Paul, AE Galván, K Yoshinaga-Sakurai, BP Rosen… - Biometals, 2023 - Springer
Arsenicals are one of the oldest treatments for a variety of human disorders. Although
infamous for its toxicity, arsenic is paradoxically a therapeutic agent that has been used …

Standardization and quality control studies of 'real-time'quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease …

J Gabert, E Beillard, VHJ Van der Velden, W Bi… - Leukemia, 2003 - nature.com
Detection of minimal residual disease (MRD) has proven to provide independent prognostic
information for treatment stratification in several types of leukemias such as childhood acute …

Nuclear structure in cancer cells

D Zink, AH Fischer, JA Nickerson - Nature reviews cancer, 2004 - nature.com
Nuclear architecture—the spatial arrangement of chromosomes and other nuclear
components—provides a framework for organizing and regulating the diverse functional …

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease

JJM Van Dongen, EA Macintyre, JA Gabert… - Leukemia, 1999 - nature.com
Prospective studies on the detection of minimal residual disease (MRD) in acute leukemia
patients have shown that large-scale MRD studies are feasible and that clinically relevant …

Mechanisms of action of arsenic trioxide

WH Miller Jr, HM Schipper, JS Lee, J Singer… - Cancer research, 2002 - AACR
Arsenic trioxide has shown substantial efficacy in treating both newly diagnosed and
relapsedpatients with acute promyelocytic leukemia (APL). As a single agent, it induces …

Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene

A Liquori, M Ibañez, C Sargas, MÁ Sanz, E Barragán… - Cancers, 2020 - mdpi.com
Although acute promyelocytic leukemia (APL) is one of the most characterized forms of
acute myeloid leukemia (AML), the molecular mechanisms involved in the development and …

Chromosomal translocation t (15; 17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

A Kakizuka, WH Miller Jr, K Umesono, RP Warrell Jr… - Cell, 1991 - cell.com
A unique mRNA produced in leukemic cells from at (15; 17) acute promyelocytic leukemia
(APL) patient encodes a fusion protein between the retinoic acid receptor a (RARa) and a …